DE602005021889D1 - Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon - Google Patents

Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon

Info

Publication number
DE602005021889D1
DE602005021889D1 DE602005021889T DE602005021889T DE602005021889D1 DE 602005021889 D1 DE602005021889 D1 DE 602005021889D1 DE 602005021889 T DE602005021889 T DE 602005021889T DE 602005021889 T DE602005021889 T DE 602005021889T DE 602005021889 D1 DE602005021889 D1 DE 602005021889D1
Authority
DE
Germany
Prior art keywords
thienopyrrolcarbonsäureamide
pyrrolothiazolcarbonsäureamide
caseinkinase
analoga
substituierte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005021889T
Other languages
German (de)
English (en)
Inventor
David Marc Fink
Yulin Chiang
Nicola Dawn Collar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE602005021889D1 publication Critical patent/DE602005021889D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
DE602005021889T 2004-08-19 2005-08-18 Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon Expired - Lifetime DE602005021889D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19
PCT/US2005/029383 WO2006021000A2 (en) 2004-08-19 2005-08-18 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number Publication Date
DE602005021889D1 true DE602005021889D1 (en) 2010-07-29

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021889T Expired - Lifetime DE602005021889D1 (en) 2004-08-19 2005-08-18 Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon

Country Status (30)

Country Link
US (2) US7393867B2 (cg-RX-API-DMAC7.html)
EP (1) EP1784409B1 (cg-RX-API-DMAC7.html)
JP (1) JP4869232B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070045263A (cg-RX-API-DMAC7.html)
CN (1) CN100562521C (cg-RX-API-DMAC7.html)
AR (1) AR051008A1 (cg-RX-API-DMAC7.html)
AT (1) ATE471326T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005272584B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514419A (cg-RX-API-DMAC7.html)
CA (1) CA2577879C (cg-RX-API-DMAC7.html)
CY (1) CY1110775T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005021889D1 (cg-RX-API-DMAC7.html)
DK (1) DK1784409T3 (cg-RX-API-DMAC7.html)
ES (1) ES2347166T3 (cg-RX-API-DMAC7.html)
GT (1) GT200500215A (cg-RX-API-DMAC7.html)
HR (1) HRP20100475T1 (cg-RX-API-DMAC7.html)
IL (1) IL181158A0 (cg-RX-API-DMAC7.html)
JO (1) JO2629B1 (cg-RX-API-DMAC7.html)
MY (1) MY139831A (cg-RX-API-DMAC7.html)
PA (1) PA8642801A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060630A1 (cg-RX-API-DMAC7.html)
PL (1) PL1784409T3 (cg-RX-API-DMAC7.html)
PT (1) PT1784409E (cg-RX-API-DMAC7.html)
RS (1) RS51413B (cg-RX-API-DMAC7.html)
RU (1) RU2403257C2 (cg-RX-API-DMAC7.html)
SI (1) SI1784409T1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002190A (cg-RX-API-DMAC7.html)
TW (1) TWI372149B (cg-RX-API-DMAC7.html)
UY (1) UY29077A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006021000A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
JP4748823B2 (ja) * 2009-02-12 2011-08-17 株式会社ファルマデザイン カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤
UA106082C2 (uk) * 2009-05-28 2014-07-25 Вертекс Фармасьютікалз Інкорпорейтед АМІНОПІРАЗОЛ ТРИАЗОЛОТІАДІАЗОЛЬНІ ІНГІБІТОРИ ПРОТЕЇНКІНАЗИ c-МЕТ
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
CN104803997A (zh) * 2010-08-09 2015-07-29 株式会社创药分子设计 酪蛋白激酶1δ及酪蛋白激酶1ε抑制剂
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
CN100439367C (zh) * 2003-12-11 2008-12-03 安万特药物公司 作为酪蛋白激酶Iε抑制剂的取代的1H-吡咯并[3,2-b、3,2-c和2,3-c]吡啶-2-甲酰胺以及相关类似物

Also Published As

Publication number Publication date
HK1105198A1 (en) 2008-02-06
PE20060630A1 (es) 2006-08-03
CN100562521C (zh) 2009-11-25
BRPI0514419A (pt) 2008-06-10
AR051008A1 (es) 2006-12-13
JP4869232B2 (ja) 2012-02-08
US7393867B2 (en) 2008-07-01
RS51413B (sr) 2011-02-28
PA8642801A1 (es) 2006-05-16
JP2008510712A (ja) 2008-04-10
ES2347166T3 (es) 2010-10-26
JO2629B1 (en) 2012-06-24
RU2007109812A (ru) 2008-09-27
CY1110775T1 (el) 2015-06-10
WO2006021000A2 (en) 2006-02-23
US20070299112A1 (en) 2007-12-27
HRP20100475T1 (hr) 2010-10-31
AU2005272584A1 (en) 2006-02-23
GT200500215A (es) 2006-03-27
US7652046B2 (en) 2010-01-26
CN101001861A (zh) 2007-07-18
TWI372149B (en) 2012-09-11
MY139831A (en) 2009-10-30
AU2005272584B2 (en) 2010-11-11
US20080227822A1 (en) 2008-09-18
PT1784409E (pt) 2010-09-06
ATE471326T1 (de) 2010-07-15
UY29077A1 (es) 2006-03-31
TW200621788A (en) 2006-07-01
SV2006002190A (es) 2006-05-24
KR20070045263A (ko) 2007-05-02
CA2577879C (en) 2011-07-12
SI1784409T1 (sl) 2010-10-29
WO2006021000A3 (en) 2006-06-15
IL181158A0 (en) 2007-07-04
RU2403257C2 (ru) 2010-11-10
EP1784409A2 (en) 2007-05-16
CA2577879A1 (en) 2006-02-23
PL1784409T3 (pl) 2010-10-29
DK1784409T3 (da) 2010-09-27
EP1784409B1 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
AP2204A (en) 4-phenylamino-quinazolin-6-yl-amides.
DE602004031777D1 (en) Thiophenderivate als chk-1-inhibitoren
EP1787458A4 (en) MACHINE LEARNING
DE602005014383D1 (en) Thienopyridinderivate als allostere gaba-b-enhancer
EP1750183A4 (en) CONTROL
GB0417789D0 (en) Access control
GB0408880D0 (en) Controller
GB0421385D0 (en) Control units
EP1779867A4 (en) MEANS FOR PROMOTING NERVE REVENERATION
EP1830858A4 (en) 3,6-BICYCLOLIDE
GB0423094D0 (en) Interrupt control
IL177662A0 (en) Novel pyrrolidine-3,4-dicarboxamide derivatives
AU302270S (en) Joystick control
AP2006003791A0 (en) 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
GB0425572D0 (en) 1,7-Naphthyridines
GB2418745B (en) I S machine
GB0521382D0 (en) Control for an I.S. machine
PL379986A1 (pl) Panel, zwłaszcza panel podłogowy
DE602005008581D1 (en) Trisubstituierte harnstoffe als cytokininhibitoren
GB0521381D0 (en) Control for an I.S. machine
DE502005010179D1 (en) Alkylcarbamat-substituierte butyrolactone als lipase-inhibitoren
GB2420725B (en) Pollution control
TWM350558U (en) Texturierduse zum texturieren von endlosgarn
GB0415061D0 (en) Control agents
AU2004900643A0 (en) Novel piperidines as CGRP ligands